Canopy Growth Reports Q2 Fiscal 2027 Revenue Growth and International Expansion Progress
Canopy Growth Corporation (CGC) reported a 22% year-over-year increase in consolidated net revenue, reaching $81.4 million for its second quarter of fiscal 2027. A significant driver of this growth was the international cannabis segment, which saw net revenue surge by 141% to $12.3 million. The company's ability to maintain end-to-end EU GMP certification across its entire supply chain positions it uniquely among Canadian competitors to capture medical cannabis market share in Europe. Operationally, the company is focusing on improving margins through cultivation upgrades at its Kincardine facility, aiming for a 25% to 30% increase in yields. Management also highlighted successful cost discipline measures within selling, general, and administrative expenses. These combined efforts are intended to drive the company toward achieving positive adjusted EBITDA in the second half of fiscal 2027.
Tickers: $CGC
Topics: cannabis industry cultivation efficiency international expansion revenue growth
Read the full article at Motley Fool
Part of the story Under Armour Reports Q2 Fiscal 2027 Revenue Decline Amid Strategic Restructuring (7 articles)